DE3671372D1 - Etoposid-praeparate. - Google Patents

Etoposid-praeparate.

Info

Publication number
DE3671372D1
DE3671372D1 DE8686300642T DE3671372T DE3671372D1 DE 3671372 D1 DE3671372 D1 DE 3671372D1 DE 8686300642 T DE8686300642 T DE 8686300642T DE 3671372 T DE3671372 T DE 3671372T DE 3671372 D1 DE3671372 D1 DE 3671372D1
Authority
DE
Germany
Prior art keywords
etoposid
preparations
etoposid preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686300642T
Other languages
German (de)
English (en)
Inventor
Takashi Terada
Hideyuki Ishimado
Masaru Suzuki
Minoru Nakada
Gen Iti Idzu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of DE3671372D1 publication Critical patent/DE3671372D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686300642T 1985-02-19 1986-01-30 Etoposid-praeparate. Expired - Lifetime DE3671372D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60031203A JPS61189230A (ja) 1985-02-19 1985-02-19 エトポシド製剤

Publications (1)

Publication Number Publication Date
DE3671372D1 true DE3671372D1 (de) 1990-06-28

Family

ID=12324856

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686300642T Expired - Lifetime DE3671372D1 (de) 1985-02-19 1986-01-30 Etoposid-praeparate.

Country Status (10)

Country Link
US (1) US4734284A (enExample)
EP (1) EP0193287B1 (enExample)
JP (1) JPS61189230A (enExample)
KR (1) KR920003332B1 (enExample)
AU (1) AU583585B2 (enExample)
DE (1) DE3671372D1 (enExample)
DK (1) DK165902C (enExample)
ES (1) ES8704727A1 (enExample)
HU (1) HU196707B (enExample)
MX (1) MX9202976A (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
CA2017916C (en) * 1989-06-07 1999-02-02 Minoru Aoki Etoposide preparations
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
WO2000045790A2 (en) * 1999-02-08 2000-08-10 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
AU2001232344A1 (en) * 2000-02-21 2001-08-27 Fujisawa Pharmaceutical Co. Ltd. Liquid preparation with improved absorbability
ATE387191T1 (de) 2002-04-25 2008-03-15 Banner Pharmacaps Inc Kaubare weichkapsel
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050220866A1 (en) * 2004-04-02 2005-10-06 Dr. Reddy's Laboratories Limited Novel capsule formulations of etoposide for oral use
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
CN104000779A (zh) 2007-04-23 2014-08-27 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
RU2753280C2 (ru) 2009-09-28 2021-08-12 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
JP7077237B2 (ja) 2016-05-16 2022-05-30 インターシア セラピューティクス，インコーポレイティド グルカゴン受容体選択的ポリペプチド及びその使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
WO2019133791A1 (en) * 2017-12-28 2019-07-04 Ackler Scott Formulations, systems, and methods for therapeutic treatment
WO2023220641A2 (en) 2022-05-11 2023-11-16 Juno Therapeutics, Inc. Methods and uses related to t cell therapy and production of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
ZA728764B (en) * 1971-12-29 1973-08-29 Squibb & Sons Inc One piece gelatin capsules containing chloral hydrate
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
DE3200766A1 (de) * 1981-01-14 1982-09-16 Toyo Jozo Kk Praeparat mit ausgezeichneter absorptionseigenschaft
JPS6032799A (ja) * 1983-07-29 1985-02-19 Microbial Chem Res Found 新規４′−デメチル−４−エピポドフィロトキシン誘導体
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US4609644A (en) * 1984-06-15 1986-09-02 St. Jude Children's Research Hospital Epipodophyllotoxinquinone glucoside derivatives, method of production and use

Also Published As

Publication number Publication date
DK165902B (da) 1993-02-08
HUT43953A (en) 1988-01-28
DK75886A (da) 1986-08-20
JPS6366810B2 (enExample) 1988-12-22
MX9202976A (es) 1992-07-01
HU196707B (en) 1989-01-30
AU5279386A (en) 1986-08-28
ES552067A0 (es) 1987-04-16
KR920003332B1 (ko) 1992-04-27
EP0193287A3 (en) 1986-10-08
EP0193287B1 (en) 1990-05-23
DK75886D0 (da) 1986-02-18
JPS61189230A (ja) 1986-08-22
ES8704727A1 (es) 1987-04-16
EP0193287A2 (en) 1986-09-03
US4734284A (en) 1988-03-29
DK165902C (da) 1993-06-28
AU583585B2 (en) 1989-05-04
KR860006263A (ko) 1986-09-09

Similar Documents

Publication Publication Date Title
DE3671372D1 (de) Etoposid-praeparate.
FI860096L (fi) Haorfaergmedels-preparat.
FI862908L (fi) Shampookompositioner.
DE3686172D1 (de) Peptid-derivate.
FI864514A7 (fi) Antiseptiska vaetskor.
FI870638A0 (fi) Uppvaermningsapparat foer under tryck staoende oeverfoeringsvaetska.
DE3766958D1 (de) Isochinolin-derivate.
FI864605L (fi) Terapeutiska sammansaettningar.
ATE50243T1 (de) Fluorbenzylester.
FI870643A7 (fi) Tislauslaite.
DE3683474D1 (de) Numerisierungsverfahren.
DE3671606D1 (de) Sichter.
DK133786D0 (da) Praeparater
NO862439D0 (no) Farmasoeytiske preparater.
NO874193D0 (no) Farmasoeytiske preparater.
FI861193L (fi) Stabilt gammainterferonpreparat.
DE3688642D1 (de) Fdm-tdm-transmultiplexer.
DK24986D0 (da) Praeparater
DE3675679D1 (de) Menschliche bauchspeichelelastase.
FR2600889B1 (fr) Preparations veterinaires.
DE3682446D1 (de) Isochinolinderivate.
NO864034D0 (no) Fungicide preparater.
DE3681759D1 (de) Abschreckverfahren.
FI881519A7 (fi) Shampoovalmisteet.
DK503386D0 (da) Peptidpraeparater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition